The group in FY2016 recorded a fair value gain of $4.5 million on its investment in China Cord Blood Corporation, which was disposed of in Oct 2015.
SINGAPORE (Aug 30): Cordlife Group, the provider of cord blood, cord tissue and umbilical cord lining banking services, sank to a loss of $2.6 million in the full year ended June, compared to earnings of $12.3 million a year ago.
This was mainly attributable to the absence of one-off gains recorded in FY2016.
